press release | highlight / actuality
A successful collaboration between chemists and biologists has identified the action of a new class of molecules, polyoxometalates, mainly composed of metals and oxygen. These molecules inhibit specifically and in a very powerful way the protein kinase CK2, a hyperactivated enzyme in many cancers. The crucial role of this enzyme in controling the proliferation and cell survival makes it an important target for drug discovery.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.